The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pain Relievers Market Research Report 2025
Synopsis
The global Pain Relievers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pain Relievers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Relievers.
Report Scope
The Pain Relievers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Relievers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Relievers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Reckitt Benckiser Group Plc
Novartis AG
Topical BioMedics
AdvaCare Pharma
Sun Pharmaceutical
Segment by Type
Nonsteroidal Anti-inflammatory Drugs
Central Analgesics
Segment by Application
Headache
Toothache
Arthralgia
Menstrual Pain
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pain Relievers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pain Relievers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pain Relievers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Relievers.
Report Scope
The Pain Relievers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pain Relievers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pain Relievers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Reckitt Benckiser Group Plc
Novartis AG
Topical BioMedics
AdvaCare Pharma
Sun Pharmaceutical
Segment by Type
Nonsteroidal Anti-inflammatory Drugs
Central Analgesics
Segment by Application
Headache
Toothache
Arthralgia
Menstrual Pain
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pain Relievers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pain Relievers Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nonsteroidal Anti-inflammatory Drugs
1.2.3 Central Analgesics
1.3 Market by Application
1.3.1 Global Pain Relievers Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Headache
1.3.3 Toothache
1.3.4 Arthralgia
1.3.5 Menstrual Pain
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pain Relievers Market Perspective (2019-2030)
2.2 Pain Relievers Growth Trends by Region
2.2.1 Global Pain Relievers Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pain Relievers Historic Market Size by Region (2019-2024)
2.2.3 Pain Relievers Forecasted Market Size by Region (2025-2030)
2.3 Pain Relievers Market Dynamics
2.3.1 Pain Relievers Industry Trends
2.3.2 Pain Relievers Market Drivers
2.3.3 Pain Relievers Market Challenges
2.3.4 Pain Relievers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pain Relievers Players by Revenue
3.1.1 Global Top Pain Relievers Players by Revenue (2019-2024)
3.1.2 Global Pain Relievers Revenue Market Share by Players (2019-2024)
3.2 Global Pain Relievers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pain Relievers Revenue
3.4 Global Pain Relievers Market Concentration Ratio
3.4.1 Global Pain Relievers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pain Relievers Revenue in 2023
3.5 Pain Relievers Key Players Head office and Area Served
3.6 Key Players Pain Relievers Product Solution and Service
3.7 Date of Enter into Pain Relievers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pain Relievers Breakdown Data by Type
4.1 Global Pain Relievers Historic Market Size by Type (2019-2024)
4.2 Global Pain Relievers Forecasted Market Size by Type (2025-2030)
5 Pain Relievers Breakdown Data by Application
5.1 Global Pain Relievers Historic Market Size by Application (2019-2024)
5.2 Global Pain Relievers Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pain Relievers Market Size (2019-2030)
6.2 North America Pain Relievers Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pain Relievers Market Size by Country (2019-2024)
6.4 North America Pain Relievers Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pain Relievers Market Size (2019-2030)
7.2 Europe Pain Relievers Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pain Relievers Market Size by Country (2019-2024)
7.4 Europe Pain Relievers Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pain Relievers Market Size (2019-2030)
8.2 Asia-Pacific Pain Relievers Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pain Relievers Market Size by Region (2019-2024)
8.4 Asia-Pacific Pain Relievers Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pain Relievers Market Size (2019-2030)
9.2 Latin America Pain Relievers Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pain Relievers Market Size by Country (2019-2024)
9.4 Latin America Pain Relievers Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pain Relievers Market Size (2019-2030)
10.2 Middle East & Africa Pain Relievers Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pain Relievers Market Size by Country (2019-2024)
10.4 Middle East & Africa Pain Relievers Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pain Relievers Introduction
11.1.4 Pfizer Revenue in Pain Relievers Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Pain Relievers Introduction
11.2.4 GSK Revenue in Pain Relievers Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Grunenthal
11.3.1 Grunenthal Company Detail
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Pain Relievers Introduction
11.3.4 Grunenthal Revenue in Pain Relievers Business (2019-2024)
11.3.5 Grunenthal Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Pain Relievers Introduction
11.4.4 Bayer Revenue in Pain Relievers Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Pain Relievers Introduction
11.5.4 Sanofi Revenue in Pain Relievers Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Pain Relievers Introduction
11.6.4 Eli Lilly Revenue in Pain Relievers Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Pain Relievers Introduction
11.7.4 AstraZeneca Revenue in Pain Relievers Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Endo
11.8.1 Endo Company Detail
11.8.2 Endo Business Overview
11.8.3 Endo Pain Relievers Introduction
11.8.4 Endo Revenue in Pain Relievers Business (2019-2024)
11.8.5 Endo Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Pain Relievers Introduction
11.9.4 Merck Revenue in Pain Relievers Business (2019-2024)
11.9.5 Merck Recent Development
11.10 Depomed
11.10.1 Depomed Company Detail
11.10.2 Depomed Business Overview
11.10.3 Depomed Pain Relievers Introduction
11.10.4 Depomed Revenue in Pain Relievers Business (2019-2024)
11.10.5 Depomed Recent Development
11.11 Yunnan Baiyao
11.11.1 Yunnan Baiyao Company Detail
11.11.2 Yunnan Baiyao Business Overview
11.11.3 Yunnan Baiyao Pain Relievers Introduction
11.11.4 Yunnan Baiyao Revenue in Pain Relievers Business (2019-2024)
11.11.5 Yunnan Baiyao Recent Development
11.12 Teva
11.12.1 Teva Company Detail
11.12.2 Teva Business Overview
11.12.3 Teva Pain Relievers Introduction
11.12.4 Teva Revenue in Pain Relievers Business (2019-2024)
11.12.5 Teva Recent Development
11.13 J&J
11.13.1 J&J Company Detail
11.13.2 J&J Business Overview
11.13.3 J&J Pain Relievers Introduction
11.13.4 J&J Revenue in Pain Relievers Business (2019-2024)
11.13.5 J&J Recent Development
11.14 Allergan
11.14.1 Allergan Company Detail
11.14.2 Allergan Business Overview
11.14.3 Allergan Pain Relievers Introduction
11.14.4 Allergan Revenue in Pain Relievers Business (2019-2024)
11.14.5 Allergan Recent Development
11.15 Purdue
11.15.1 Purdue Company Detail
11.15.2 Purdue Business Overview
11.15.3 Purdue Pain Relievers Introduction
11.15.4 Purdue Revenue in Pain Relievers Business (2019-2024)
11.15.5 Purdue Recent Development
11.16 Reckitt Benckiser Group Plc
11.16.1 Reckitt Benckiser Group Plc Company Detail
11.16.2 Reckitt Benckiser Group Plc Business Overview
11.16.3 Reckitt Benckiser Group Plc Pain Relievers Introduction
11.16.4 Reckitt Benckiser Group Plc Revenue in Pain Relievers Business (2019-2024)
11.16.5 Reckitt Benckiser Group Plc Recent Development
11.17 Novartis AG
11.17.1 Novartis AG Company Detail
11.17.2 Novartis AG Business Overview
11.17.3 Novartis AG Pain Relievers Introduction
11.17.4 Novartis AG Revenue in Pain Relievers Business (2019-2024)
11.17.5 Novartis AG Recent Development
11.18 Topical BioMedics
11.18.1 Topical BioMedics Company Detail
11.18.2 Topical BioMedics Business Overview
11.18.3 Topical BioMedics Pain Relievers Introduction
11.18.4 Topical BioMedics Revenue in Pain Relievers Business (2019-2024)
11.18.5 Topical BioMedics Recent Development
11.19 AdvaCare Pharma
11.19.1 AdvaCare Pharma Company Detail
11.19.2 AdvaCare Pharma Business Overview
11.19.3 AdvaCare Pharma Pain Relievers Introduction
11.19.4 AdvaCare Pharma Revenue in Pain Relievers Business (2019-2024)
11.19.5 AdvaCare Pharma Recent Development
11.20 Sun Pharmaceutical
11.20.1 Sun Pharmaceutical Company Detail
11.20.2 Sun Pharmaceutical Business Overview
11.20.3 Sun Pharmaceutical Pain Relievers Introduction
11.20.4 Sun Pharmaceutical Revenue in Pain Relievers Business (2019-2024)
11.20.5 Sun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pain Relievers Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Nonsteroidal Anti-inflammatory Drugs
Table 3. Key Players of Central Analgesics
Table 4. Global Pain Relievers Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Pain Relievers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pain Relievers Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Pain Relievers Market Share by Region (2019-2024)
Table 8. Global Pain Relievers Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Pain Relievers Market Share by Region (2025-2030)
Table 10. Pain Relievers Market Trends
Table 11. Pain Relievers Market Drivers
Table 12. Pain Relievers Market Challenges
Table 13. Pain Relievers Market Restraints
Table 14. Global Pain Relievers Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Pain Relievers Market Share by Players (2019-2024)
Table 16. Global Top Pain Relievers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Relievers as of 2023)
Table 17. Ranking of Global Top Pain Relievers Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Pain Relievers Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pain Relievers Product Solution and Service
Table 21. Date of Enter into Pain Relievers Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pain Relievers Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Pain Relievers Revenue Market Share by Type (2019-2024)
Table 25. Global Pain Relievers Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Pain Relievers Revenue Market Share by Type (2025-2030)
Table 27. Global Pain Relievers Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Pain Relievers Revenue Market Share by Application (2019-2024)
Table 29. Global Pain Relievers Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Pain Relievers Revenue Market Share by Application (2025-2030)
Table 31. North America Pain Relievers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Pain Relievers Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Pain Relievers Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Pain Relievers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Pain Relievers Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Pain Relievers Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Pain Relievers Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Pain Relievers Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Pain Relievers Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pain Relievers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Pain Relievers Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Pain Relievers Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Pain Relievers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Pain Relievers Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Pain Relievers Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Pain Relievers Product
Table 49. Pfizer Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. GSK Company Detail
Table 52. GSK Business Overview
Table 53. GSK Pain Relievers Product
Table 54. GSK Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Grunenthal Company Detail
Table 57. Grunenthal Business Overview
Table 58. Grunenthal Pain Relievers Product
Table 59. Grunenthal Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 60. Grunenthal Recent Development
Table 61. Bayer Company Detail
Table 62. Bayer Business Overview
Table 63. Bayer Pain Relievers Product
Table 64. Bayer Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. Sanofi Company Detail
Table 67. Sanofi Business Overview
Table 68. Sanofi Pain Relievers Product
Table 69. Sanofi Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Eli Lilly Company Detail
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Pain Relievers Product
Table 74. Eli Lilly Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 75. Eli Lilly Recent Development
Table 76. AstraZeneca Company Detail
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Pain Relievers Product
Table 79. AstraZeneca Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Endo Company Detail
Table 82. Endo Business Overview
Table 83. Endo Pain Relievers Product
Table 84. Endo Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 85. Endo Recent Development
Table 86. Merck Company Detail
Table 87. Merck Business Overview
Table 88. Merck Pain Relievers Product
Table 89. Merck Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Depomed Company Detail
Table 92. Depomed Business Overview
Table 93. Depomed Pain Relievers Product
Table 94. Depomed Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 95. Depomed Recent Development
Table 96. Yunnan Baiyao Company Detail
Table 97. Yunnan Baiyao Business Overview
Table 98. Yunnan Baiyao Pain Relievers Product
Table 99. Yunnan Baiyao Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 100. Yunnan Baiyao Recent Development
Table 101. Teva Company Detail
Table 102. Teva Business Overview
Table 103. Teva Pain Relievers Product
Table 104. Teva Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 105. Teva Recent Development
Table 106. J&J Company Detail
Table 107. J&J Business Overview
Table 108. J&J Pain Relievers Product
Table 109. J&J Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 110. J&J Recent Development
Table 111. Allergan Company Detail
Table 112. Allergan Business Overview
Table 113. Allergan Pain Relievers Product
Table 114. Allergan Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 115. Allergan Recent Development
Table 116. Purdue Company Detail
Table 117. Purdue Business Overview
Table 118. Purdue Pain Relievers Product
Table 119. Purdue Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 120. Purdue Recent Development
Table 121. Reckitt Benckiser Group Plc Company Detail
Table 122. Reckitt Benckiser Group Plc Business Overview
Table 123. Reckitt Benckiser Group Plc Pain Relievers Product
Table 124. Reckitt Benckiser Group Plc Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 125. Reckitt Benckiser Group Plc Recent Development
Table 126. Novartis AG Company Detail
Table 127. Novartis AG Business Overview
Table 128. Novartis AG Pain Relievers Product
Table 129. Novartis AG Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 130. Novartis AG Recent Development
Table 131. Topical BioMedics Company Detail
Table 132. Topical BioMedics Business Overview
Table 133. Topical BioMedics Pain Relievers Product
Table 134. Topical BioMedics Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 135. Topical BioMedics Recent Development
Table 136. AdvaCare Pharma Company Detail
Table 137. AdvaCare Pharma Business Overview
Table 138. AdvaCare Pharma Pain Relievers Product
Table 139. AdvaCare Pharma Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 140. AdvaCare Pharma Recent Development
Table 141. Sun Pharmaceutical Company Detail
Table 142. Sun Pharmaceutical Business Overview
Table 143. Sun Pharmaceutical Pain Relievers Product
Table 144. Sun Pharmaceutical Revenue in Pain Relievers Business (2019-2024) & (US$ Million)
Table 145. Sun Pharmaceutical Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pain Relievers Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pain Relievers Market Share by Type: 2023 VS 2030
Figure 3. Nonsteroidal Anti-inflammatory Drugs Features
Figure 4. Central Analgesics Features
Figure 5. Global Pain Relievers Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Pain Relievers Market Share by Application: 2023 VS 2030
Figure 7. Headache Case Studies
Figure 8. Toothache Case Studies
Figure 9. Arthralgia Case Studies
Figure 10. Menstrual Pain Case Studies
Figure 11. Other Case Studies
Figure 12. Pain Relievers Report Years Considered
Figure 13. Global Pain Relievers Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Pain Relievers Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Pain Relievers Market Share by Region: 2023 VS 2030
Figure 16. Global Pain Relievers Market Share by Players in 2023
Figure 17. Global Top Pain Relievers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Relievers as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Pain Relievers Revenue in 2023
Figure 19. North America Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Pain Relievers Market Share by Country (2019-2030)
Figure 21. United States Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Pain Relievers Market Share by Country (2019-2030)
Figure 25. Germany Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Pain Relievers Market Share by Region (2019-2030)
Figure 33. China Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Pain Relievers Market Share by Country (2019-2030)
Figure 41. Mexico Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Pain Relievers Market Share by Country (2019-2030)
Figure 45. Turkey Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Pain Relievers Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 48. GSK Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 49. Grunenthal Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 50. Bayer Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 51. Sanofi Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 52. Eli Lilly Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 53. AstraZeneca Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 54. Endo Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 55. Merck Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 56. Depomed Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 57. Yunnan Baiyao Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 58. Teva Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 59. J&J Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 60. Allergan Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 61. Purdue Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 62. Reckitt Benckiser Group Plc Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 63. Novartis AG Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 64. Topical BioMedics Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 65. AdvaCare Pharma Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 66. Sun Pharmaceutical Revenue Growth Rate in Pain Relievers Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
